Turnstone Biologics Corp. (TSBX)
(Delayed Data from NSDQ)
$0.36 USD
+0.01 (1.43%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $0.36 +0.01 (1.41%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Turnstone Biologics Corp.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
TSBX 0.36 +0.01(1.43%)
Will TSBX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TSBX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TSBX
Turnstone Biologics Corp. (TSBX) Upgraded to Buy: What Does It Mean for the Stock?
TSBX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TSBX
Turnstone Biologics to be acquired by XOMA Royalty
Turnstone Biologics (TSBX) Agrees to Acquisition by XOMA Royalty | TSBX Stock News
Xoma to acquire Turnstone Biologics for $0.34 in cash per share
Xoma to acquire Turnstone Biologics for $0.34 in cash per share
Turnstone Biologics Corp. Enters Merger Agreement with XOMA